Thinking of switching to Mounjaro? Here's what Amy Schumer has to say about the new 'weight loss drug'
Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy.
Medical Dialogues27m
New research-Improving GLP-1 drug delivery by ‘painting’ it on antibodies
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.
Irish Medical Times6h
Weight loss drug Wegovy now available in Ireland
Semaglutide is already available in Ireland through diabetes medication Ozempic. However, its producer Novo Nordisk uses the ...
PipelineReview.com1h
The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
GUANGDONG, China and BAGSVAERD, Denmark I March 24, 2025 IThe United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) ...
Connecticut Public5h
People call GLP-1s life-changing. CT says it can’t afford them.
GLP-1 weight loss drugs cost CT’s Medicaid program $85 million in FY 2024, 35% of annual Medicaid pharmaceutical budget ...